Reaction Details |
| Report a problem with these data |
Target | Alpha-2C adrenergic receptor |
---|
Ligand | BDBM643031 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | In Vitro Radioligand Binding Assay |
---|
IC50 | 1.50±n/a nM |
---|
Citation | DELBECK, M; HAHN, M COMBINATION OF AN ALPHA2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA US Patent US20240000767 Publication Date 1/4/2024 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Alpha-2C adrenergic receptor |
---|
Name: | Alpha-2C adrenergic receptor |
Synonyms: | ADA2C_HUMAN | ADRA2C | ADRA2L2 | ADRA2RL2 | Adrenergic alpha2C | Adrenergic receptor | Adrenergic receptor alpha | Adrenergic, alpha-2C-, receptor | Alpha-2 adrenergic receptor subtype C4 | Alpha-2C adrenoceptor | Alpha-2C adrenoreceptor | adrenergic, alpha-2C-, receptor [Homo sapiens] |
Type: | Enzyme |
Mol. Mass.: | 49552.32 |
Organism: | Homo sapiens (Human) |
Description: | P18825 |
Residue: | 462 |
Sequence: | MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGF
LIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFG
QVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISA
VISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLR
TRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGA
LRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRR
RRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFK
FFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ
|
|
|
BDBM643031 |
---|
n/a |
---|
Name | BDBM643031 |
Synonyms: | US20240000767, Example 110 | rac-2-{3-[(3,3-Difluorocyclobutyl)oxy][1,4′-bipiperidin]-1′-yl}-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide |
Type | Small organic molecule |
Emp. Form. | C24H29F4N5O2S |
Mol. Mass. | 527.578 |
SMILES | Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)OC2CC(F)(F)C2)c(F)c1 |
Structure |
|